![](/img/cover-not-exists.png)
P2.03a-018 A Phase I/II Study of Alisertib, an Oral Aurora Kinase Inhibitor, in Combination with Erlotinib in Patients with Recurrent or Metastatic NSCLC
Godwin, James, Bauman, Jessica, Litwin, Samuel, Mehra, Ranee, Olszanski, Anthony, Borghaei, HosseinVolume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.1227
Date:
January, 2017
File:
PDF, 175 KB
english, 2017